Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance)

Autor: Unger, JM, Phillips, K-A, Boyle, FM, Hitre, E, Porter, DJ, Francis, PA, Minasian, LM, Gelber, RD, Goldstein, LJ, Gomez, HL, Vallejos, C, Partridge, AH, Dakhil, SR, Martino, S, Barlow, WE, Fabian, CJ, Meyskens, FL, Hortobagyi, GN, Albain, KS

Publikováno v: Unger, JM; Phillips, K-A; Boyle, FM; Hitre, E; Porter, DJ; Francis, PA; et al.(2014). Phase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32(18_suppl), LBA505. doi: 10.1200/jco.2014.32.18_suppl.lba505. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/3rg743fk

LBA505 Background: Premature ovarian failure (POF) is a common toxicity of CT. Risk depends on type and amount of CT, age, and perhaps ovarian cycling at the time of CT. POEMS is a SWOG-coordinated phase III randomized study to evaluate whether LHRH

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::371872d38470b88fa0b752c584339a02
http://www.escholarship.org/uc/item/3rg743fk

Herschel-ATLAS : multi-wavelength SEDs and physical properties of 250 µm selected galaxies at z < 0.5

Autor: Smith, DJB, Dunne, L, da Cunha, E, Rowlands, K, Maddox, SJ, Gomez, HL, Bonfield, DG, Charlot, S, Driver, SP, Popescu, CC, Tuffs, RJ, Dunlop, JS, Jarvis, MJ, Seymour, N, Symeonidis, M, Baes, Maarten, Bourne, N, Clements, DL, Cooray, A, De Zotti, G, Dye, S, Eales, S, Scott, D, Verma, A, van der Werf, P, Andrae, E, Auld, R, Buttiglione, S, Cava, A, Dariush, A, Fritz, Jacopo, Hopwood, R, Ibar, E, Ivison, RJ, Kelvin, L, Madore, BF, Pohlen, M, Rigby, EE, Robotham, A, Seibert, M, Temi, P

Publikováno v: MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY

We present a pan-chromatic analysis of an unprecedented sample of 1402 250 mu m selected galaxies at z < 0.5 ( = 0.24) from the Herschel-ATLAS survey. We complement our Herschel 100-500 mu m data with UV-K-band photometry from the Galaxy And Mass Ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______330::07cf67f09d4011c493b75c1dfdd28832
https://hdl.handle.net/1854/LU-3080182

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.

Autor: Di Leo A, Gomez HL, Aziz Z, Zvirbule Z, Bines J, Arbushites MC, Guerrera SF, Koehler M, Oliva C, Stein SH, Williams LS, Dering J, Finn RS, Press MF, Di Leo, Angelo, Gomez, Henry L, Aziz, Zeba, Zvirbule, Zanete, Bines, Jose, Arbushites, Michael C

Publikováno v: Journal of Clinical Oncology; 12/1/2008, Vol. 26 Issue 34, p5544-5552, 9p

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

Autor: Thomas ES, Gomez HL, Li RK, Chung HC, Fein LE, Chan VF, Jassem J, Pivot XB, Klimovsky JV, de Mendoza FH, Xu B, Campone M, Lerzo GL, Peck RA, Mukhopadhyay P, Vahdat LT, Roché HH, Thomas, Eva S, Gomez, Henry L, Li, Rubi K

Publikováno v: Journal of Clinical Oncology; 11/20/2007, Vol. 25 Issue 33, p5210-5217, 8p